Buy Pfizer Here: Income, Upside Optionality and a Manageable Risk-Reward
Pfizer trades near its 52-week low with a 6.66% yield, a modest P/B of 1.63 and a market cap of ~$147.5B. Operational growth from newly acquired oncology assets is visible, but headline earnings slipped. This trade captures income while positioning for a rebound if execution holds; define risk tightly and size accordingly.